Yamaguchi K - Search Results

1

Menstrual cyclic change of metastin/GPR54 in endometrium.

Baba T, Kang HS, Hosoe Y, Kharma B, Abiko K, Matsumura N, Hamanishi J, Yamaguchi K, Yoshioka Y, Koshiyama M, Mandai M, Murphy SK, Konishi I. Baba T, et al. Among authors: yamaguchi k. Med Mol Morphol. 2015 Jun;48(2):76-84. doi: 10.1007/s00795-014-0081-0. Epub 2014 Jun 8. Med Mol Morphol. 2015. PMID: 24908069

2

Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression.

Miyanishi M, Mandai M, Matsumura N, Yamaguchi K, Hamanishi J, Higuchi T, Takakura K, Fujii S. Miyanishi M, et al. Among authors: yamaguchi k. Oncol Rep. 2007 Feb;17(2):329-33. Oncol Rep. 2007. PMID: 17203169

3

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.

Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N, Honjo T, Fujii S. Hamanishi J, et al. Among authors: yamaguchi k. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3360-5. doi: 10.1073/pnas.0611533104. Epub 2007 Feb 21. Proc Natl Acad Sci U S A. 2007. PMID: 17360651 Free PMC article.

4

Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress.

Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S. Yamaguchi K, et al. Clin Cancer Res. 2008 Jan 1;14(1):32-40. doi: 10.1158/1078-0432.CCR-07-1614. Clin Cancer Res. 2008. PMID: 18172249

5

Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ovarian cancer treatment.

Matsumura N, Mandai M, Hamanishi J, Yamaguchi K, Fukuhara K, Yagi H, Higuchi T, Takakura K, Fujii S. Matsumura N, et al. Among authors: yamaguchi k. Oncol Rep. 2008 Feb;19(2):505-15. Oncol Rep. 2008. PMID: 18202801

6

Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period.

Yamaguchi K, Mandai M, Fukuhara K, Higuchi T, Hamanishi J, Takakura K, Fujii S. Yamaguchi K, et al. Oncol Rep. 2008 Mar;19(3):705-11. Oncol Rep. 2008. PMID: 18288405

7

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.

Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, Yagi H, Yamaguchi K, Baba T, Fujii S, Konishi I. Li K, et al. Among authors: yamaguchi k. Cancer Immunol Immunother. 2009 May;58(5):641-52. doi: 10.1007/s00262-008-0585-3. Epub 2008 Sep 13. Cancer Immunol Immunother. 2009. PMID: 18791713 Free PMC article.

8

Targeting slow-proliferating ovarian cancer cells.

Kondoh E, Mori S, Yamaguchi K, Baba T, Matsumura N, Cory Barnett J, Whitaker RS, Konishi I, Fujii S, Berchuck A, Murphy SK. Kondoh E, et al. Among authors: yamaguchi k. Int J Cancer. 2010 May 15;126(10):2448-56. doi: 10.1002/ijc.24919. Int J Cancer. 2010. PMID: 19795452 Free article.

9

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I. Mandai M, et al. Among authors: yamaguchi k. Int J Clin Oncol. 2009 Oct;14(5):383-91. doi: 10.1007/s10147-009-0935-y. Epub 2009 Oct 25. Int J Clin Oncol. 2009. PMID: 19856044 Review.

10

Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer.

Hamanishi J, Mandai M, Matsumura N, Baba T, Yamaguchi K, Fujii S, Konishi I. Hamanishi J, et al. Among authors: yamaguchi k. Stem Cells. 2010 Jan;28(1):164-73. doi: 10.1002/stem.256. Stem Cells. 2010. PMID: 19911426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,511 results

Search Page